Supplemental material
Expert Opinion on Drug Delivery
Volume 21, 2024 - Issue 2
Open access
769
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatment
Evelyn Cottella Merck Healthcare KGaA, Darmstadt, GermanyView further author information
, Damien Michaletb Ares Trading S.A. Eysins (An affiliate of Merck KGaA), SwitzerlandView further author information
, Monica Lispia Merck Healthcare KGaA, Darmstadt, Germany;c School of Clinical and Experimental Medicine, Unit of Endocrinology, University of Modena and Reggio Emilia, Modena, MO, ItalyView further author information
, Thiago Dantas Araujob Ares Trading S.A. Eysins (An affiliate of Merck KGaA), SwitzerlandView further author information
, Ralf Gleixnerb Ares Trading S.A. Eysins (An affiliate of Merck KGaA), SwitzerlandView further author information
, Salvatore Longobardid Global Clinical Development, Merck Serono S.p.A, Rome, Italy, an affiliate of Merck KGaA, Darmstadt, GermanyView further author information
& Thomas D’Hooghea Merck Healthcare KGaA, Darmstadt, Germany;e Department of Development and Regeneration, Laboratory of Endometrium, Endometriosis & Reproductive Medicine, KU Leuven, Leuven, Belgium;f Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University Medical School, New Haven, CT, USACorrespondence[email protected]
View further author information
show allView further author information
Pages 337-346
|
Received 10 Jun 2022, Accepted 20 Jan 2024, Published online: 02 Feb 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.